Aimmune Therapeutics

AIMT

35.74

+0.16

+0.5%

After Hours:

35.74

0.00

0.0%

Please Login or Register

Login|Register FREE

Stock Price
Open: 35.50
Prev. Close: 35.58
Low/Hi: 35.41 - 35.92
52-Week: 15.97 - 37.50
Volumes
Equity: 191,329
90-Day Avg: 421,551
Option: 222
90-Day Avg: 388
Volatility
Todays Stock Vol: 13.3
20-Day (HV): 55.7
52-Week (HV): 47.8
30-Day IV: 54.6 +2.4
IV Pct Rank: 2% Subdued
Fundamental
Div. Yield:
Earnings: 8-Mar (Est.)
P/E Ratio:
Market Cap: 1.8 B
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

AIMT Cash Flow

Numbers are in thousands. Data provided by Sage Data Service.
Period Ending 30-Sep-2017 30-Jun-2017 31-Mar-2017 31-Dec-2016
Net Income -31,792 -32,497 -25,870 -25,076
Change in Working Capital 2,692 7,471 -1,183 -1,396
Depreciation Amortization Depletion and Accretion 393 403 384 -607
Deferred Taxes 0 0 0 0
Other Non-Cash Activities 4,381 4,375 3,579 4,467
Total Cash from Operating Activities -24,326 -20,248 -23,104 -22,612
Capital Expenditures -2,401 -1,951 -900 -940
Other Investing Cash Flow 14,648 27,551 -22,410 -76,391
Total Cash from Investing Activities 12,247 25,600 -23,310 -77,331
Dividends and Distributions 0 0 0 0
Purchase or Sale of Stock 1,449 385 1,118 147,042
Purchase and Retirement of Debt 0 0 0 0
Other Financing Cash Flow 0 0 0 0
Total Cash from Financing Activities 1,449 385 1,118 147,042
Exchange Rate Effects 0 0 0 0
Net Change in Cash -10,630 5,737 -45,296 47,099
Period Ending 31-Dec-2016 31-Dec-2015 31-Dec-2014
Net Income -80,824 -35,816 -11,120
Change in Working Capital 10,116 -6,470 1,237
Depreciation Amortization Depletion and Accretion 534 115 29
Deferred Taxes 0 0 0
Other Non-Cash Activities 13,560 6,481 77
Total Cash from Operating Activities -56,614 -35,690 -9,777
Capital Expenditures -7,665 -1,708 -56
Other Investing Cash Flow -36,231 -123,521 -40
Total Cash from Investing Activities -43,896 -125,229 -96
Dividends and Distributions 0 0 0
Purchase or Sale of Stock 147,843 235,327 191
Purchase and Retirement of Debt 0 0 0
Other Financing Cash Flow 0 0 0
Total Cash from Financing Activities 147,843 235,327 191
Exchange Rate Effects 0 0 0
Net Change in Cash 47,333 74,408 -9,682